Metastasis
is
the
major
cause
of
cancer-related
death,
and
lymph
node
most
common
site
metastasis
in
breast
cancer.
However,
alterations
that
happen
tumor-draining
nodes
(TDLNs)
to
form
a
premetastatic
microenvironment
are
largely
unknown.
Here,
we
first
report
dynamic
changes
size
immune
status
TDLNs
before
With
progression
tumor,
TDLN
enlarged
immune-activated
at
early
stage
contains
specific
antitumor
immunity
against
metastasis.
The
then
contracted
immunosuppressed
late
finally
getting
metastasized.
Mechanistically,
B
follicular
helper
T
(Tfh)
cells
parallelly
expand
contract
determine
TDLN.
activation
CD8+
determined
by
interleukin-21
(IL-21)
produced
Tfh
cells,
thus
showing
parallel
changes.
turn
from
activated
enlargement
suppressed
contraction
due
spontaneous
germinal
centers
mediated
regulatory
cells.
On
basis
B-Tfh-IL-21-CD8+
cell
axis,
prove
targeting
axis
could
activate
resist
Together,
our
findings
identify
mechanisms
cancer
provide
new
strategies
inhibit
Journal of Hematology & Oncology,
Год журнала:
2023,
Номер
16(1)
Опубликована: Сен. 12, 2023
Abstract
Lipid
metabolic
reprogramming
is
an
emerging
hallmark
of
cancer.
In
order
to
sustain
uncontrolled
proliferation
and
survive
in
unfavorable
environments
that
lack
oxygen
nutrients,
tumor
cells
undergo
transformations
exploit
various
ways
acquiring
lipid
increasing
oxidation.
addition,
stromal
immune
the
microenvironment
also
reprogramming,
which
further
affects
functional
phenotypes
responses.
Given
metabolism
plays
a
critical
role
supporting
cancer
progression
remodeling
microenvironment,
targeting
pathway
could
provide
novel
approach
treatment.
This
review
seeks
to:
(1)
clarify
overall
landscape
mechanisms
cancer,
(2)
summarize
landscapes
within
their
roles
progression,
(3)
potential
therapeutic
targets
for
metabolism,
highlight
combining
such
approaches
with
other
anti-tumor
therapies
new
opportunities
patients.
Signal Transduction and Targeted Therapy,
Год журнала:
2024,
Номер
9(1)
Опубликована: Март 25, 2024
Abstract
The
innate
immune
pathway
is
receiving
increasing
attention
in
cancer
therapy.
This
ubiquitous
across
various
cell
types,
not
only
cells
but
also
adaptive
cells,
tumor
and
stromal
cells.
Agonists
targeting
the
have
shown
profound
changes
microenvironment
(TME)
improved
prognosis
preclinical
studies.
However,
to
date,
clinical
success
of
drugs
remains
limited.
Interestingly,
recent
studies
that
activation
can
paradoxically
promote
progression.
uncertainty
surrounding
therapeutic
effectiveness
targeted
for
a
critical
issue
needs
immediate
investigation.
In
this
review,
we
observe
role
demonstrates
heterogeneity,
linked
development
stage,
status,
specific
types.
We
propose
within
TME,
exhibits
multidimensional
diversity.
diversity
fundamentally
rooted
cellular
heterogeneity
manifested
as
variety
signaling
networks.
pro-tumor
effect
essentially
reflects
suppression
classical
pathways
potential
alternative
pathways.
Refining
our
understanding
tumor’s
network
employing
appropriate
strategies
enhance
ability
harness
anti-tumor
ultimately
bridge
gap
from
application.
Signal Transduction and Targeted Therapy,
Год журнала:
2025,
Номер
10(1)
Опубликована: Фев. 18, 2025
Abstract
Breast
cancer,
characterized
by
unique
epidemiological
patterns
and
significant
heterogeneity,
remains
one
of
the
leading
causes
malignancy-related
deaths
in
women.
The
increasingly
nuanced
molecular
subtypes
breast
cancer
have
enhanced
comprehension
precision
treatment
this
disease.
mechanisms
tumorigenesis
progression
been
central
to
scientific
research,
with
investigations
spanning
various
perspectives
such
as
tumor
stemness,
intra-tumoral
microbiota,
circadian
rhythms.
Technological
advancements,
particularly
those
integrated
artificial
intelligence,
significantly
improved
accuracy
detection
diagnosis.
emergence
novel
therapeutic
concepts
drugs
represents
a
paradigm
shift
towards
personalized
medicine.
Evidence
suggests
that
optimal
diagnosis
models
tailored
individual
patient
risk
expected
are
crucial,
supporting
era
oncology
for
cancer.
Despite
rapid
advancements
increasing
emphasis
on
clinical
comprehensive
update
summary
panoramic
knowledge
related
disease
needed.
In
review,
we
provide
thorough
overview
global
status
including
its
epidemiology,
factors,
pathophysiology,
subtyping.
Additionally,
elaborate
latest
research
into
contributing
progression,
emerging
strategies,
long-term
management.
This
review
offers
valuable
insights
Cancer
Research,
thereby
facilitating
future
progress
both
basic
application.
Lipids in Health and Disease,
Год журнала:
2024,
Номер
23(1)
Опубликована: Фев. 1, 2024
Abstract
Lipid
metabolism
in
cancer
cells
has
garnered
increasing
attention
recent
decades.
Cancer
thrive
hypoxic
conditions,
nutrient
deficiency,
and
oxidative
stress
cannot
be
separated
from
alterations
lipid
metabolism.
Therefore,
exhibit
increased
metabolism,
uptake,
lipogenesis
storage
to
adapt
a
progressively
challenging
environment,
which
contribute
their
rapid
growth.
Lipids
aid
cell
activation.
absorb
lipids
with
the
help
of
transporter
translocase
proteins
obtain
energy.
Abnormal
levels
series
synthases
over-accumulation
tumor
microenvironment
(TME).
reprogramming
plays
an
essential
role
TME.
are
closely
linked
several
immune
phenotypic
transformation.
The
further
promotes
immunosuppression,
leads
escape.
This
event
significantly
affects
progression,
treatment,
recurrence,
metastasis
cancer.
present
review
describes
TME
examines
connection
between
immunotherapy.
Biomarker Research,
Год журнала:
2024,
Номер
12(1)
Опубликована: Сен. 3, 2024
Abstract
Tumor
cells
possess
complex
immune
evasion
mechanisms
to
evade
system
attacks,
primarily
through
metabolic
reprogramming,
which
significantly
alters
the
tumor
microenvironment
(TME)
modulate
cell
functions.
When
a
is
sufficiently
immunogenic,
it
can
activate
cytotoxic
T-cells
target
and
destroy
it.
However,
tumors
adapt
by
manipulating
their
pathways,
particularly
glucose,
amino
acid,
lipid
metabolism,
create
an
immunosuppressive
TME
that
promotes
escape.
These
alterations
impact
function
differentiation
of
non-tumor
within
TME,
such
as
inhibiting
effector
T-cell
activity
while
expanding
regulatory
myeloid-derived
suppressor
cells.
Additionally,
these
changes
lead
imbalance
in
cytokine
chemokine
secretion,
further
enhancing
landscape.
Emerging
research
increasingly
focusing
on
roles
evaluating
how
reprogrammed
metabolism
influence
functional
ultimately
aid
evasion.
Despite
our
incomplete
understanding
intricate
interactions
between
cells,
connection
elements
presents
significant
challenges
for
cancer
immunotherapy.
This
review
highlights
altered
providing
new
insights
could
facilitate
development
novel
immunotherapies.
Metabolic
reprogramming
within
the
tumor
microenvironment
(TME)
is
a
hallmark
of
cancer
and
crucial
determinant
progression.
Research
indicates
that
various
metabolic
regulators
form
network
in
TME
interact
with
immune
cells,
coordinating
response.
dysregulation
creates
an
immunosuppressive
TME,
impairing
antitumor
In
this
review,
we
discuss
how
affect
cell
crosstalk
TME.
We
also
summarize
recent
clinical
trials
involving
challenges
metabolism-based
therapies
translation.
word,
our
review
distills
key
regulatory
factors
their
mechanisms
action
from
complex
metabolism,
identified
as
regulators.
These
provide
theoretical
basis
research
direction
for
development
new
strategies
targets
therapy
based
on
reprogramming.
Refining
Depicting
between
stromal
cells
during
Emphasizing
unresolved
translation
advantages
personalized
treatment.
Providing
support
therapies.
Extracellular Vesicles and Circulating Nucleic Acids,
Год журнала:
2023,
Номер
4(3), С. 461 - 485
Опубликована: Янв. 1, 2023
Over
the
past
decade,
extracellular
vesicles
and
particles
(EVPs)
have
emerged
as
critical
mediators
of
intercellular
communication,
participating
in
numerous
physiological
pathological
processes.
In
context
cancer,
EVPs
exert
local
effects,
such
increased
invasiveness,
motility,
reprogramming
tumor
stroma,
well
systemic
including
pre-metastatic
niche
formation,
determining
organotropism,
promoting
metastasis
altering
homeostasis
various
organs
systems,
liver,
muscle,
circulatory
system.
This
review
provides
an
overview
advances
EVP
research
during
highlighting
heterogeneity
EVPs,
their
roles
cancer
progression,
metastasis.
Moreover,
clinical
potential
useful
biomarkers
therapeutic
agents
is
explored.
Last
but
not
least,
progress
analysis
technologies
that
facilitated
these
discoveries
discussed,
which
may
further
propel
future.
Theranostics,
Год журнала:
2023,
Номер
13(7), С. 2301 - 2318
Опубликована: Янв. 1, 2023
Breast
cancer
(BC)
is
one
of
the
most
commonly
diagnosed
cancers
and
leading
cause
cancer-related
deaths
in
women
worldwide.Metastasis
a
major
contributor
to
high
mortality
usually
endpoint
series
sequential
dynamic
events.One
critical
events
forming
pre-metastatic
niche
(PMN)
that
occurs
before
macroscopic
tumor
cell
invasion
provides
suitable
environment
for
cells
colonize
progress
into
metastases.Due
unique
characteristics
PMN
metastasis,
developing
therapies
target
may
bring
new
advantages
preventing
metastasis
at
an
early
stage.Various
biological
molecules,
cells,
signaling
pathways
are
altered
BC,
regulating
functions
distinctive
immune
stromal
remodeling,
inducing
angiogenesis,
effect
metabolic
reprogramming
organotropism
promote
formation.In
this
review,
we
elucidate
multifaceted
mechanisms
contributing
development
discuss
PMN,
highlight
significance
providing
potential
diagnostic
therapeutic
strategies
BC
which
promising
insights
foundations
future
studies.
Journal of Nanobiotechnology,
Год журнала:
2024,
Номер
22(1)
Опубликована: Март 15, 2024
Abstract
The
challenges
posed
by
delayed
atrophic
healing
and
nonunion
stand
as
formidable
obstacles
in
osteoporotic
fracture
treatment.
processes
of
type
H
angiogenesis
osteogenesis
emerge
pivotal
mechanisms
during
bone
regeneration.
Notably,
the
preconditioning
adipose-derived
stem
cell
(ADSC)
exosomes
under
hypoxic
conditions
has
garnered
attention
for
its
potential
to
augment
secretion
functionality
these
exosomes.
In
present
investigation,
we
embarked
upon
a
comprehensive
elucidation
underlying
hypo-ADSC-Exos
within
milieu
Our
findings
revealed
that
harboured
preeminent
miRNA,
namely,
miR-21-5p,
which
emerged
principal
orchestrator
angiogenic
effects.
Through
vitro
experiments,
demonstrated
capacity
stimulate
proliferation,
migration,
human
umbilical
vein
endothelial
cells
(HUVECs)
via
mediation
miR-21-5p.
inhibition
miR-21-5p
effectively
attenuated
proangiogenic
effects
mediated
hypo-ADSC-Exos.
Mechanistically,
our
investigation
exosomal
emanating
from
hypo-ADSCs
exerts
regulatory
influence
targeting
sprouly1
(SPRY1)
HUVECs,
thereby
facilitating
activation
PI3K/AKT
signalling
pathway.
knockdown
SPRY1
HUVECs
was
found
potentiate
and,
concomitantly,
HUVEC
angiogenesis.
culminating
stage
study
involved
compelling
vivo
demonstration
wherein
GelMA
loaded
with
validated
substantially
enhance
local
concomitant
This
enhancement
unequivocally
attributed
modulation
SPRY1.
summary,
offers
pioneering
perspective
on
utility
readily
available
Graphical